Skip to main content
TipRanks
Go Ultimate75% OFF

Cryo-Cell International (ZCY) Stock Price & Analysis

0 Followers

ZCY Stock Chart & Stats

€3.50-€0.60(-14.63%)
At close: 5:30 PM GMT+1
€3€3.5€4Sep 16Oct 15Oct 16Nov 18
Day’s Range
EUR 3.50 - EUR 3.52
52-Week Range
EUR 2.32 - EUR 4.52
Previous Close
EUR 4.10
Volume
N/A
Average Volume (3M)
100
Market Cap
EUR 30.49M
Enterprise Value
EUR 38.46M
Total Cash (Recent Filing)
EUR 4.23M
Total Debt (Recent Filing)
EUR 577.20K
Price to Earnings (P/E)
―
Beta
0.25
Next Earnings
Feb 26, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Positive Cash Generation

Positive operating and free cash flow provide internal funding for ongoing operations and reduce immediate reliance on external capital. Cash generation has remained positive from 2024 through TTM, supporting business resilience even while reported net income is negative.

Strong Gross Margin

A gross margin near 77% indicates the core service offering retains substantial value after direct costs. If maintained, this creates room to absorb operating expenses, invest in customer acquisition and preserve cash generation as the business scales.

Recurring Storage Revenue Model

The combination of upfront processing revenue and recurring long-term storage fees can build a durable revenue base as new enrollments accumulate. Client retention and prepaid plans may improve revenue visibility and support continued cash generation over multiple periods.

Bears Say

Negative Stockholders’ Equity

Deeply negative equity signals a strained capital structure and reduces financial flexibility, even though total debt is lower than in earlier years. The company may have less capacity to absorb operating setbacks or fund initiatives without rebuilding its balance sheet.

Persistent Net Losses

Current losses indicate that the company’s strong gross margin is not translating consistently into bottom-line earnings. Near-breakeven operating profit leaves limited room for cost increases or execution setbacks, while earnings volatility makes future profitability less dependable.

Weak Revenue And Cash-Flow Momentum

Flat-to-declining revenue limits the company’s ability to expand its customer base and spread fixed costs, while sharply lower free cash flow indicates deteriorating cash momentum. Together, these trends could constrain investment and make the recent cash generation less durable.

Cryo-Cell International News

ZCY FAQ

What was Cryo-Cell International’s price range in the past 12 months?
Cryo-Cell International lowest stock price was €2.32 and its highest was €4.52 in the past 12 months.
What is Cryo-Cell International’s market cap?
Cryo-Cell International’s market cap is €30.49M.
When is Cryo-Cell International’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cryo-Cell International’s earnings last quarter?
Cryo-Cell International released its earnings results on Oct 09, 2026. The company reported €0.143 earnings per share for the quarter, beating the consensus estimate of €0.027 by €0.116.
Is Cryo-Cell International overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Cryo-Cell International pay dividends?
Cryo-Cell International does not currently pay dividends.
What is Cryo-Cell International’s EPS estimate?
Cryo-Cell International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cryo-Cell International have?
Cryo-Cell International has 8,062,650 shares outstanding.
What happened to Cryo-Cell International’s price movement after its last earnings report?
Cryo-Cell International reported an EPS of €0.143 in its last earnings report, beating expectations of €0.027. Following the earnings report the stock price went up 8.14%.
Which hedge fund is a major shareholder of Cryo-Cell International?
Currently, no hedge funds are holding shares in DE:ZCY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology